ChromaDex
 | |
| Company type | Public |
|---|---|
| Nasdaq: CDXC Russell 2000 Index component | |
| Industry | Dietary supplements, food ingredients, chemical sample analysis |
| Founded | 1999 |
| Headquarters | Los Angeles, California, United States |
Key people | Rob Fried (CEO) Frank Jaksch (Co-Founder, Executive Chairman) |
| Products | Tru Niagen |
| Website | www |
ChromaDex is a dietary supplement and food ingredient company based in Los Angeles, California founded in 1999 that is publicly traded on the NASDAQ.
In 2011, ChromaDex licensed patents from Dartmouth College, Cornell University, and Washington University in St. Louis regarding nicotinamide riboside, which it markets and sells as an ingredient under the brand name Niagen and sells directly to consumers as Tru Niagen.[1] ChromaDex licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound under the brand name pTeroPure.[2] ChromaDex no longer sells pTeroPure.[3]
ChromaDex also licensed patents from the University of Mississippi on Immulina, a proprietary extract of Arthrospira platensis (or spirulina, a type of algae) which it continues to sell today as an ingredient for use in dietary supplements.
History
Founded in 1999 by Frank Jaksch, ChromaDex first acquired licensed Dartmouth patents on nicotinamide riboside in 2012, leading to the commercialization of Niagen in 2013.
ChromaDex is traded on the NASDAQ (as CDXC) as of April 2016 and was added to the U.S. Small Cap Russell 2000 Index in June 2018.
In 2017, the company acquired HealthSpan Research LLC and its product Tru Niagen, a standalone nicotinamide riboside supplement, sold direct to U.S. consumers. Also in 2017, ChromaDex raised $48 million, led by Horizons Ventures, the investment firm of Hong Kong billionaire Li Ka-Shing, as well as venture capitalists and strategic investors, including ICONIQ Capital, to support research and development, and global expansion.
Awards
NutraIngredients, a leading news source for the nutrition industry, recently honored the ChromaDex External Research Program (CERP) with a 2022 European NutraIngredients Award in the “Nutrition Research Project” category for developing the science behind patented Niagen. In 2019, NutraIngredients awarded Tru Niagen the Ingredient of the Year award in the Healthy Aging category.
Tru Niagen is one of Amazon U.S.’s top-selling brands in the vitamin B3 category for boosting NAD+ levels as of December 2022.
References
- ^ Weintraub, Karen. "The Life Extension Death Match". NEO.LIFE.
- ^ Neeb, Matthew (2011-06-20). "Ole Miss grants exclusive patent rights to ChromaDex Corp". The Daily Mississippian. Archived from the original on 2012-04-18. Retrieved 2012-05-25.
- ^ Krawiec, Sebastian (2018-10-31). "ChromaDex ceases new pterostilbene orders based on research demonstrating increase in LDL cholesterol". Nutritional Outlook. Retrieved 2020-05-01.